BANK OF MONTREAL /CAN/ - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 74 filers reported holding GALENA BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2016$10,000
-81.5%
31,230
-73.2%
0.00%
Q2 2016$54,000
+25.6%
116,617
+268.1%
0.00%
Q1 2016$43,000
+975.0%
31,682
+1003.1%
0.00%
Q4 2015$4,000
+33.3%
2,872
+70.7%
0.00%
Q3 2015$3,000
-90.6%
1,682
-91.0%
0.00%
Q2 2015$32,000
+3100.0%
18,752
+2393.6%
0.00%
Q1 2015$1,0000.0%7520.0%0.00%
Q4 2014$1,000
-88.9%
752
-75.3%
0.00%
Q2 2014$9,0003,0500.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,446,469$13,616,0002.03%
Harbour Capital Advisors, LLC 78,450$196,0000.19%
SABBY MANAGEMENT, LLC 708,089$1,770,0000.10%
TENOR CAPITAL MANAGEMENT Co., L.P. 174,600$437,0000.07%
Alyeska Investment Group, L.P. 530,000$1,950,0000.05%
HIGHLAND CAPITAL MANAGEMENT LP 528,027$1,320,0000.05%
KMS FINANCIAL SERVICES, INC 118,042$295,0000.05%
Quantitative Investment Management, LLC 348,500$871,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 538,100$1,345,0000.04%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 29,675$74,0000.04%
View complete list of GALENA BIOPHARMA INC shareholders